Related Experiment Video
Updated: Feb 13, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
Sexual health in patients with hematological malignancies: a neglected issue
Pasquale Niscola1, Fabio Efficace2, Elisabetta Abruzzese3
1Hematology Unit, Sant'Eugenio Hospital, Piazzale dell'Umanesimo, 10, 00144, Rome, Italy. pniscola@gmail.com.
Insights
Sexual dysfunction is a significant issue for patients with hematologic malignancies (HM), impacting their quality of life (QoL). Further research is needed to understand the effects of new HM treatments on sexual health and overall QoL.
Area of Science:
- Oncology
- Hematology
- Sexual Medicine
Background:
- Sexual dysfunction is a common yet underrecognized symptom in patients with hematologic malignancies (HM).
- Current quality of life (QoL) assessments for HM patients often overlook sexual health concerns.
- Limited research exists on the impact of HM and its treatments on sexual well-being.
Purpose of the Study:
- To investigate the prevalence and impact of sexual dysfunction in patients with hematologic malignancies (HM).
- To explore the relationship between sexual health and overall quality of life (QoL) in HM patients.
- To assess the influence of novel therapies, including targeted treatments, on sexual health outcomes in HM.
Main Methods:
- Review of existing literature on sexual dysfunction in HM patients.
- Analysis of QoL assessment tools used in HM care.
- Exploration of emerging data on newer HM drug classes and their potential effects on sexual health.
Main Results:
- Evidence suggests sexual dysfunction is a prominent symptom burden for HM patients.
- Sexual health is frequently omitted from QoL evaluations in this population.
- There is a significant gap in research regarding sexual health and HM treatments.
Conclusions:
- Sexual health is a critical, yet underaddressed, component of QoL for patients with HM.
- Further investigation is warranted to understand the impact of contemporary HM therapies on sexual function and QoL.
- Integrating sexual health assessments into routine HM care is essential for comprehensive patient management.
Abstract:
Current evidence, although limited, outlines that sexual dysfunction may represent a prominent part of the symptom burden experienced by the patients with hematologic malignancies (HM). However, despite their presumed negative effects on quality of life (QoL), sexual health is not typically considered in the QoL assessment of HM patients. In addition, very few studies have been conducted in this area. Therefore, it would be important to further investigate how newer drugs developed in recent years for patients with HM, including targeted therapies and impact on sexual health, and how this influence overall patients' QoL outcomes.
Related Concept Videos
Ethical Issues
Ethical Concerns in Healthcare:
Sexually Transmitted Infections
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Development of the Sexual Organs in the Embryo and Fetus
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the...
Health Literacy

